ASTROTECH Corp Finance Lease, Right-of-Use Asset, Amortization
ASTROTECH Corp (ASTC) reported Finance Lease, Right-of-Use Asset, Amortization of $31.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q/A filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2026-08-06
- ASTROTECH Corp finance lease, right-of-use asset, amortization for the quarter ending 2026-03-31 was $31.00K, a 0.00% change year-over-year.
- ASTROTECH Corp finance lease, right-of-use asset, amortization for the quarter ending 2025-12-31 was $31.00K, a 0.00% change year-over-year.
- ASTROTECH Corp finance lease, right-of-use asset, amortization for the quarter ending 2025-09-30 was $31.00K, a 0.00% change year-over-year.
- ASTROTECH Corp finance lease, right-of-use asset, amortization for the quarter ending 2025-06-30 was $57.00K, a 90.00% increase year-over-year.
- ASTROTECH Corp finance lease, right-of-use asset, amortization for fiscal 2025 was $126.00K, a 1.61% increase from fiscal 2024.
- ASTROTECH Corp finance lease, right-of-use asset, amortization for fiscal 2024 was $124.00K, a 22.77% increase from fiscal 2023.
- ASTROTECH Corp finance lease, right-of-use asset, amortization for fiscal 2023 was $101.00K, a 65.57% increase from fiscal 2022.
- ASTROTECH Corp finance lease, right-of-use asset, amortization for fiscal 2022 was $61.00K.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 3 month as first filed | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|---|
| 2026-03-31 | $31.00K 10-Q/A · filed 2026-08-06 | $62.00K derived: sum of 2 quarters · filed 2026-08-06 | $95.00K 10-Q/A · filed 2026-08-06 | $150.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $31.00K 10-Q · filed 2026-02-13 | $63.00K 10-Q · filed 2026-02-13 | $119.00K derived: sum of 3 quarters · filed 2026-02-13 | $150.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-09-30 | $31.00K 10-Q · filed 2025-11-13 | $88.00K derived: sum of 2 quarters · filed 2025-11-13 | $119.00K derived: sum of 3 quarters · filed 2026-08-06 | $150.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $57.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2025-09-26 | $88.00K derived: sum of 2 quarters · filed 2026-08-06 | $119.00K derived: sum of 3 quarters · filed 2026-08-06 | $126.00K 10-K · filed 2025-09-26 | |
| 2025-03-31 | $31.00K 10-Q/A · filed 2026-08-06 | $7.00K 10-Q · filed 2025-05-14 | $62.00K derived: sum of 2 quarters · filed 2026-08-06 | $69.00K 10-Q/A · filed 2026-08-06 | $123.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2024-12-31 | $31.00K 10-Q · filed 2026-02-13 | $63.00K 10-Q · filed 2026-02-13 | $92.00K derived: sum of 3 quarters · filed 2026-02-13 | $123.00K derived: sum of 4 quarters · filed 2026-02-13 | |
| 2024-09-30 | $31.00K 10-Q · filed 2025-11-13 | $61.00K derived: sum of 2 quarters · filed 2025-11-13 | $92.00K derived: sum of 3 quarters · filed 2025-11-13 | $123.00K derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-26 | $61.00K derived: sum of 2 quarters · filed 2025-09-26 | $92.00K derived: sum of 3 quarters · filed 2025-09-26 | $124.00K 10-K · filed 2025-09-26 | |
| 2024-03-31 | $31.00K 10-Q · filed 2025-05-14 | $94.00K 10-Q · filed 2024-05-14 | $62.00K derived: sum of 2 quarters · filed 2025-05-14 | $94.00K 10-Q · filed 2025-05-14 | $118.00K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $31.00K 10-Q · filed 2025-02-14 | $72.00K 10-Q · filed 2025-02-14 | $87.00K derived: sum of 3 quarters · filed 2025-02-14 | $163.00K derived: sum of 4 quarters · filed 2025-02-14 | |
| 2023-09-30 | $31.00K 10-Q · filed 2024-11-13 | $56.00K derived: sum of 2 quarters · filed 2024-11-13 | $132.00K derived: sum of 3 quarters · filed 2024-11-13 | $157.00K derived: sum of 4 quarters · filed 2024-11-13 | |
| 2023-06-30 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-20 | $101.00K derived: sum of 2 quarters · filed 2024-09-20 | $126.00K derived: sum of 3 quarters · filed 2024-09-20 | $101.00K 10-K · filed 2024-09-20 | |
| 2023-03-31 | $76.00K 10-Q · filed 2024-05-14 | $101.00K derived: sum of 2 quarters · filed 2024-05-14 | $76.00K 10-Q · filed 2024-05-14 | ||
| 2022-12-31 | $25.00K 10-Q · filed 2024-02-13 | $50.00K 10-Q · filed 2024-02-13 | |||
| 2022-09-30 | $26.00K 10-Q · filed 2023-11-13 | ||||
| 2022-06-30 | $61.00K 10-K · filed 2023-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |